PAVmed (PAVM) Equity Ratio (2015 - 2025)

PAVmed's Equity Ratio history runs 11 years deep, the most recent figure standing at 0.57 for Q4 2025.

• In Q4 2025, Equity Ratio rose 806.06% year-over-year to 0.57; the TTM figure through Dec 2025 stood at 0.57 (up 806.06% YoY), while the FY2025 annual figure was 0.57, up 806.06% from the prior year.
• Equity Ratio was 0.57 for Q4 2025 at PAVmed, down from 0.85 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.94 in Q1 2021 to a low of 0.73 in Q4 2023.
• Historically, Equity Ratio has averaged 0.33 across 5 years, with a median of 0.45 in 2022.
• The sharpest annual moves came in 2021 and 2024: Equity Ratio surged 3918.04% in 2021, then slumped 2959.23% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.91 in 2021, then plunged by 77.82% to 0.2 in 2022, then slumped by 458.03% to 0.73 in 2023, then jumped by 88.78% to 0.08 in 2024, then soared by 806.06% to 0.57 in 2025.
• The last three Equity Ratio figures came in at 0.57 (Q4 2025), 0.85 (Q3 2025), and 0.64 (Q2 2025), per Business Quant data.